Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Mammography Data Compression, QC Concerns Weighed By Panel

This article was originally published in The Gray Sheet

Executive Summary

Differences between film and full-field digital mammography complicate quality control testing of the digital systems and slow facility accreditation, according to FDA's National Mammography Quality Assurance Advisory Committee

You may also be interested in...



Hologic Selenia

American College of Radiology is authorized to accredit facilities that use the full-field digital mammography systems, effective Sept. 15. Prior to FDA sign-off for ACR accreditation, facilities using the device had to file directly with the agency for an MQSA certification extension to include the system and have a back-up screen-film. The device debuted earlier this year. ACR already has accreditation authority for Fischer's SenoScan and GE Medical Systems' Senographe 2000D FFDM systems (1"The Gray Sheet" Aug. 11, 2003, p. 19)...

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020112

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel